Prevalence of HLA-B27, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis.

MLA

Jittawattanarat, Boonsiri, et al. “Prevalence of HLA-B27, Clinical Characteristics and Treatment Outcomes in Children with Enthesitis-Related Arthritis.” BMC Pediatrics, vol. 24, no. 1, Aug. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12887-024-05032-2.

APA

Jittawattanarat, B., Charuvanij, S., Tangcheewinsirikul, S., & Sukharomana, M. (2024). Prevalence of HLA-B27, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis. BMC Pediatrics, 24(1), 1–12. https://doi.org/10.1186/s12887-024-05032-2

Chicago

Jittawattanarat, Boonsiri, Sirirat Charuvanij, Sirikarn Tangcheewinsirikul, and Maynart Sukharomana. 2024. “Prevalence of HLA-B27, Clinical Characteristics and Treatment Outcomes in Children with Enthesitis-Related Arthritis.” BMC Pediatrics 24 (1): 1–12. doi:10.1186/s12887-024-05032-2.